Herriot Tabuteau insider trades

Open-market stock purchases and sales by Herriot Tabuteau, Chief Executive Officer at Axsome Therapeutics, Inc, from SEC Form 4 filings since Nov 24, 2015.

Recent trades

DateStockTradeValue
Aug 6, 2026AXSM Axsome Therapeutics, IncSold$997K
Aug 6, 2026AXSM Axsome Therapeutics, IncBought (not open market)$23.1K
Aug 6, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Aug 5, 2026AXSM Axsome Therapeutics, IncSold$9.5M
Aug 5, 2026AXSM Axsome Therapeutics, IncBought (not open market)$223K
Aug 5, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Jul 1, 2026AXSM Axsome Therapeutics, IncSold$11.9M
Jul 1, 2026AXSM Axsome Therapeutics, IncBought (not open market)$246K
Jul 1, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Jun 9, 2026AXSM Axsome Therapeutics, IncSold$12M
Jun 9, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Apr 21, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Feb 26, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Feb 2, 2026AXSM Axsome Therapeutics, IncSold$6M
Feb 2, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Jan 7, 2026AXSM Axsome Therapeutics, IncSold$5.3M
Jan 7, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Jan 6, 2026AXSM Axsome Therapeutics, IncSold$5.1M
Jan 6, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Jan 5, 2026AXSM Axsome Therapeutics, IncSold$13.5M
Jan 5, 2026AXSM Axsome Therapeutics, IncBought (not open market)—
Dec 4, 2025AXSM Axsome Therapeutics, IncSold$1.6M
Dec 4, 2025AXSM Axsome Therapeutics, IncBought (not open market)—
Dec 3, 2025AXSM Axsome Therapeutics, IncBought (not open market)—
Dec 3, 2025AXSM Axsome Therapeutics, IncSold$3M

Companies traded

  • AXSM Axsome Therapeutics, Inc: 20 sales, last Aug 6, 2026

Get free alerts when Herriot Tabuteau files a new trade →